Ten Berge IJ - Search Results

1

Immunization after renal transplantation: current clinical practice.

Struijk GH, Lammers AJ, Brinkman RJ, Lombarts MJ, van Vugt M, van der Pant KA, Ten Berge IJ, Bemelman FJ. Struijk GH, et al. Among authors: ten berge ij. Transpl Infect Dis. 2015 Apr;17(2):192-200. doi: 10.1111/tid.12368. Transpl Infect Dis. 2015. PMID: 25662181

2

Pretreatment with divided doses of steroids strongly decreases side effects of OKT3.

Bemelman FJ, Buysmann S, Surachno J, Wilmink JM, Schellekens PT, ten Berge IJ. Bemelman FJ, et al. Among authors: ten berge ij. Kidney Int. 1994 Dec;46(6):1674-9. doi: 10.1038/ki.1994.467. Kidney Int. 1994. PMID: 7700026 Free article.

3

Toxicity of OKT3 increases with dosage: a controlled study in renal transplant recipients.

Parlevliet KJ, Bemelman FJ, Yong SL, Hack CE, Surachno J, Wilmink JM, ten Berge IJ, Schellekens PT. Parlevliet KJ, et al. Among authors: ten berge ij. Transpl Int. 1995;8(2):141-6. doi: 10.1007/BF00344424. Transpl Int. 1995. PMID: 7766296 Clinical Trial.

4

Serum neopterin/creatinine values correlate with severity of symptoms caused by cytomegalovirus infection in renal transplant recipients.

Raasveld MH, Bloemena E, Wertheim-van Dillen P, Surachno J, Wilmink JM, ten Berge IJ. Raasveld MH, et al. Among authors: ten berge ij. Transpl Int. 1993 Jan;6(1):42-4. doi: 10.1007/BF00336639. Transpl Int. 1993. PMID: 8383975

5

Complement activation during OKT3 treatment: a possible explanation for respiratory side effects.

Raasveld MH, Bemelman FJ, Schellekens PT, van Diepen FN, van Dongen A, van Royen EA, Hack CE, ten Berge IJ. Raasveld MH, et al. Among authors: ten berge ij. Kidney Int. 1993 May;43(5):1140-9. doi: 10.1038/ki.1993.160. Kidney Int. 1993. PMID: 8510394 Free article.

6

Activation and increased expression of adhesion molecules on peripheral blood lymphocytes is a mechanism for the immediate lymphocytopenia after administration of OKT3.

Buysmann S, Bemelman FJ, Schellekens PT, van Kooyk Y, Figdor CG, ten Berge IJ. Buysmann S, et al. Among authors: ten berge ij. Blood. 1996 Jan 1;87(1):404-11. Blood. 1996. PMID: 8547669 Free article.

7

Primary immune responses to human CMV: a critical role for IFN-gamma-producing CD4+ T cells in protection against CMV disease.

Gamadia LE, Remmerswaal EB, Weel JF, Bemelman F, van Lier RA, Ten Berge IJ. Gamadia LE, et al. Among authors: ten berge ij. Blood. 2003 Apr 1;101(7):2686-92. doi: 10.1182/blood-2002-08-2502. Epub 2002 Oct 31. Blood. 2003. PMID: 12411292 Free article.

8

Treatment of acute kidney allograft rejection with a non-mitogenic CD3 antibody.

Meijer RT, Surachno S, Yong SL, Bemelman FJ, Florquin S, Ten Berge IJ, Schellekens PT. Meijer RT, et al. Among authors: ten berge ij. Clin Exp Immunol. 2003 Sep;133(3):485-92. doi: 10.1046/j.1365-2249.2003.02200.x. Clin Exp Immunol. 2003. PMID: 12930378 Free PMC article. Clinical Trial.

9

Hyperexpression of the granzyme B inhibitor PI-9 in human renal allografts: a potential mechanism for stable renal function in patients with subclinical rejection.

Rowshani AT, Florquin S, Bemelman F, Kummer JA, Hack CE, Ten Berge IJ. Rowshani AT, et al. Among authors: ten berge ij. Kidney Int. 2004 Oct;66(4):1417-22. doi: 10.1111/j.1523-1755.2004.00903.x. Kidney Int. 2004. PMID: 15458434 Free article.

10

Falciparum malaria transmitted by a thick blood smear negative kidney donor.

Bemelman F, De Blok K, De Vries P, Surachno S, Ten Berge I. Bemelman F, et al. Scand J Infect Dis. 2004;36(10):769-71. doi: 10.1080/00365540410020901a. Scand J Infect Dis. 2004. PMID: 15513408

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

254 results

Search Page

Filters